Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Celera Corporation Stories

2014-03-25 08:30:12

- Effort designed to help revolutionize access to genomic interpretation services in hospitals, molecular diagnostics companies and academic medical centers throughout the U.S. - ROCKVILLE and BALTIMORE, Md., March 25, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand) and BioHealth Innovation, Inc. (BHI) today announced a strategic partnership designed to expand the Strand Centers for Genomics & Personalized Medicine into the U.S. This effort is intended to help revolutionize...

2014-03-11 08:29:49

SAN DIEGO, March 11, 2014 /PRNewswire/ -- BioNano Genomics announced today the appointment of Mr. Joel Jung as chief financial officer. Mr. Jung has more than 17 years of experience in corporate finance and executive leadership of private and public biotech companies. "Joel is an experienced finance executive who has spent nearly two decades guiding financial strategy in the high-tech and biotechnology industries," said Erik Holmlin, president and CEO of BioNano Genomics. "Joel's...

2013-12-31 16:22:17

Brings advanced genomics software within broader reach to enable biomarker discovery and precision medicine SALT LAKE CITY, Dec. 31, 2013 /PRNewswire-iReach/ -- Tute Genomics announced that it has raised $1.5 million in Seed Round funding to further develop its advanced genome analysis software, allowing researchers to rapidly discover novel disease genes & identify predictive biomarkers. Investors in this round include Wilmington Pharmatech, Salt Lake Life Sciences Angels, Peak...

2013-11-04 15:26:36

As one of the most influential and fruitful annual conference in "Omics", the 8th International Conference on Genomics (ICG-8) was successfully concluded on November 1st with numerous updates provided on on-going research applying today's accurate and affordable technologies to advancing human health and agricultural breeding. The three-day conference, co-organized by BGI and GigaScience Journal, also provided an excellent platform for deeply discussing the challenges and opportunities...

2013-10-23 08:30:14

CAMBRIDGE, Mass., Oct. 23, 2013 /PRNewswire/ -- NextCODE Health, a new private company enabling accelerated diagnosis of genetic diseases through the use of sequence data, announced today that it has secured an exclusive license for sequence-based clinical diagnostic applications using technology developed by deCODE genetics. The company also secured $15 million in Series A financing from Polaris Partners and ARCH Venture Partners, which will allow NextCODE to rapidly scale the integration...

2013-10-01 16:26:15

MADISON, N.J. and SYDNEY, Oct. 1, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013 it completed the sale of its Enterix colorectal cancer screening test business to Clinical Genomics Technologies Pty Ltd., an Australian life sciences company. Terms of the transaction were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO ) At its Investor Day...

2013-09-11 23:19:44

The Port incubator continues to concentrate a global network of innovators within the Philadelphia region. Philadelphia, Pa. (PRWEB) September 11, 2013 BGI Health Americas, a U.S. subsidiary of BGI, one of the world’s leading research and genomics institutions, has opened an office at the University City Science Center’s Port business incubator. Founded in Beijing in 1999 as Beijing Genomics Institute, BGI uses advanced technology platforms to study genetic structure, gene function...

2013-08-19 23:04:45

Bina Accelerates Fast and Accurate Genomic Interpretation at a Fraction of the Cost of Whole Genome Analysis Redwood City, CA (PRWEB) August 19, 2013 Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced the launch of its Whole Exome application and Bina On-Demand offering, the latest additions to the company’s fully integrated Bina Genomic Analysis Platform, which performs whole genome analysis in 4 hours or less. Exome sequencing...

2013-08-07 08:30:13

-- Merger will make DNA testing more accessible and affordable for consumers, researchers and healthcare providers -- HOUSTON, Aug. 7, 2013 /PRNewswire/ -- Gene by Gene, Ltd., the world's first company to develop consumer DNA testing products for ancestry and genealogy applications, announced today the acquisition of Arpeggi, Inc., a StartUp Health- and GE-backed company that develops solutions for genome sequencing, data management and computational analysis. The combined company...

2013-07-18 08:28:53

Retains royalty rights to odanacatib and other Celera drug assets MADISON, N.J. and NEW YORK, July 18, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products,...